Outcome of Endometrial Carcinoma Patients with Involvement of the Uterine Serosa

By Ashman J.B.   Connell P.P.   Yamada D.   Rotmensch J.   Waggoner S.E.   Mundt A.J.  

Gynecologic Oncology, Vol. 82, Iss. 2, 2001-08 ,pp. : 338-343

Elsevier

Access to resources Recommend Favorite

Prognostic Significance of Progesterone Receptor Immunohistochemistry in Endometrial Carcinoma

By Fukuda K.   Mori M.   Uchiyama M.   Iwai K.   Iwasaka T.   Sugimori H.  

Gynecologic Oncology, Vol. 69, Iss. 3, 1998-06 ,pp. : 220-225

Elsevier

Access to resources Recommend Favorite

Prognostic Significance of Vascular Endothelial Growth Factor and Its Receptors in Endometrial Carcinoma

By Yokoyama Y.   Sato S.   Futagami M.   Fukushi Y.   Sakamoto T.   Umemoto M.   Saito Y.  

Gynecologic Oncology, Vol. 77, Iss. 3, 2000-06 ,pp. : 413-418

Elsevier

Access to resources Recommend Favorite

MIB-1 in Endometrial Carcinoma: Prognostic Significance with 5-Year Follow-Up

By Geisler J.P.   Geisler H.E.   Miller G.A.   Wiemann M.C.   Zhou Z.   Crabtree W.  

Gynecologic Oncology, Vol. 75, Iss. 3, 1999-12 ,pp. : 432-436

Elsevier

Access to resources Recommend Favorite

Prognostic Significance of Progesterone Receptor Immunohistochemistry for Lymph Node Metastases in Endometrial Carcinoma

By Iwai K.   Fukuda K.   Hachisuga T.   Mori M.   Uchiyama M.   Iwasaka T.   Sugimori H.  

Gynecologic Oncology, Vol. 72, Iss. 3, 1999-03 ,pp. : 351-359

Elsevier

Access to resources Recommend Favorite